Zhejiang Cancer Hospital: Stomach Neoplasms trials

The registry lists 20 Stomach Neoplasms studies with Zhejiang Cancer Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 8Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant AscitesRecruitingNCT07855640
• Clinical Evaluation of GRAPE Model for Gastric Cancer ScreeningRecruitingNCT07067983
• Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric CancerNot yet recruitingNCT06437678Phase 2
• Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes MechanismsRecruitingNCT06078930
• Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant AscitesRecruitingNCT06046963Phase 2
• Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric CancerNot yet recruitingNCT05669807Phase 2
• HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal MetastasisNot yet recruitingNCT04889768Not applicable
• Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant AscitesActive, not recruitingNCT07855757Not applicable
• A Multi-omics-based Metabolic Typing Study of Gastric CancerActive, not recruitingNCT06134011
• Preliminary Experimental Study on Key Technologies for Early Screening of Gastric CancerStatus unknownNCT05991947
• DLCS for Predicting Neoadjuvant Chemotherapy ResponseStatus unknownNCT05617469
• Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT05528367Phase 2
• A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric CancerStatus unknownNCT05385809
• Early Detection of Gastric Cancer Using Plasma Cell-free DNA FragmentomicsStatus unknownNCT05269056
• Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric CancerStatus unknownNCT04135781Phase 3
• Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT03276156Phase 1
• HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal MetastasisStatus unknownNCT02549911Phase 2
• D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric CancerStatus unknownNCT01836991Phase 2
• Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric CancerStatus unknownNCT01756183Phase 2
• Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric CancerStatus unknownNCT01558947Phase 2